CluePoints
ActiveSummary
CluePoints has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8.1m and a net result of €3.6m. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 36% of 5,017 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- Other function
- began earlier
| Name | Functions and periods |
|---|---|
| KPMG Réviseurs d'Entreprises |
|
| Amit Patel |
|
| Andrew Cooper |
|
| François Torche |
|
| Marc BUYSE |
|
| Marc Melviez |
|
| Olivier Belenger |
|
| Patrick Hughes |
|
| Thomas Tarnowski |
|
| CLINIMETRICS |
|
| Innovative Minds |
|
| INTERNATIONAL DRUG DEVELOPMENT INSTITUTE |
|
| Marie Bouillez |
|
Owners and capital
Owners
3 ownersChain of control
- CLUEDO BIDCO LTDGB
- Cluedo Bidco
- CluePoints
Highest known parent: CLUEDO BIDCO LTD (United Kingdom). The sources do not say who stands above it.
Owners 3
- Cluedo Bidcoparent100%
- CLUEDO BIDCO LTDGBconsolidating parentconsolidates
- 10.62%
According to the 2025 annual accounts of CluePoints and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 18-09-2024 Capital stated in the deed · €767,580
- 17-07-2024 Capital stated in the deed · €6,719,197.35 · 237,373 shares
- 08-12-2023 Capital increase of €376,239.33 · to €5,951,617.35 · 14,877 new shares · in cash